Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2230540 | 0.73 | CTSD (0.43) | CTSD | |
| Hydrochloric Acid SCHEMBL9079390 | 0.69 | CTSD (0.32) | CTSD | |
| Hydrochloric Acid SCHEMBL7869576 | 0.67 | CTSD (0.35) | CTSD | |
| SCHEMBL28961651 | 0.65 | CTSD (0.38) | CTSD | |
| Hydrochloric Acid SCHEMBL9247457 | 0.65 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL1539601 | 0.65 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL149637 | 0.65 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL22660514 | 0.65 | CTSD (0.33) | CTSD | |
| Hydrochloric Acid SCHEMBL9576657 | 0.65 | CTSD (0.33) | CTSD | |
| SCHEMBL9452777 | 0.65 | CTSD (0.33) | CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10322999-B2 | Oxindoles derivatives, preparation method thereof and pharmaceutical compositions for the prevention or treatment of cancer containing the same as an active ingredient | Research & Business Foundation Sungkyunkwan University (KR) | 2019-06-18 | — | — | US | disclosed |
| US-20180339965-A1 | OXINDOLES DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CANCER CONTAINING THE SAME AS AN ACTIVE INGREDIENT | Research & Business Foundation Sungkyunkwan University (KR) | 2018-11-29 | — | — | US | disclosed |
| CN-106632087-A | Preparation method of 4-aryl-2- (2- (sulfur trifluoromethyl) aryl) quinazoline | 江西师范大学 | 2017-05-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180339965-A1 | OXINDOLES DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CANCER CONTAINING THE SAME AS AN ACTIVE INGREDIENT | ODC1, CCNI, CYP3A5 | CTSD 3207/4885 |
| US-10322999-B2 | Oxindoles derivatives, preparation method thereof and pharmaceutical compositions for the prevention or treatment of cancer containing the same as an active ingredient | ODC1, CCNI, CYP3A5 | CTSD 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.